Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

Abstract

The prevalence of HIV-associated PAH is about the same as it was in the early 1990s. Given the current good long-term prognosis of patients with HIV, the severity of PAH in HIV-infected patients, and the absence of predictive factors, careful screening for PAH is warranted for patients with unexplained dyspnea.